207 related articles for article (PubMed ID: 27888884)
21. Oncogenic mechanisms in Burkitt lymphoma.
Schmitz R; Ceribelli M; Pittaluga S; Wright G; Staudt LM
Cold Spring Harb Perspect Med; 2014 Feb; 4(2):. PubMed ID: 24492847
[TBL] [Abstract][Full Text] [Related]
22. The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.
Smith SM; Anastasi J; Cohen KS; Godley LA
Blood Cells Mol Dis; 2010 Dec; 45(4):317-23. PubMed ID: 20817505
[TBL] [Abstract][Full Text] [Related]
23. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
[TBL] [Abstract][Full Text] [Related]
24. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
Ruzinova MB; Caron T; Rodig SJ
Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
[TBL] [Abstract][Full Text] [Related]
25. Decitabine represses translocated MYC oncogene in Burkitt lymphoma.
Guan H; Xie L; Klapproth K; Weitzer CD; Wirth T; Ushmorov A
J Pathol; 2013 Apr; 229(5):775-83. PubMed ID: 23341364
[TBL] [Abstract][Full Text] [Related]
26. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.
Ott G; Rosenwald A; Campo E
Hematology Am Soc Hematol Educ Program; 2013; 2013():575-83. PubMed ID: 24319234
[TBL] [Abstract][Full Text] [Related]
27. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.
Lynnhtun K; Renthawa J; Varikatt W
Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699
[TBL] [Abstract][Full Text] [Related]
28. Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein.
Fest T; Guffei A; Williams G; Silva S; Mai S
Oncogene; 2005 Apr; 24(18):2944-53. PubMed ID: 15735723
[TBL] [Abstract][Full Text] [Related]
29. Emerging molecular networks in Burkitt's lymphoma.
Mangani D; Roberti A; Rizzolio F; Giordano A
J Cell Biochem; 2013 Jan; 114(1):35-8. PubMed ID: 22903691
[TBL] [Abstract][Full Text] [Related]
30. Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation - how to treat?
Zhang C; Amos Burke GA
Leuk Lymphoma; 2018 Aug; 59(8):1807-1813. PubMed ID: 29022749
[TBL] [Abstract][Full Text] [Related]
31. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
32. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
Lindström MS; Klangby U; Wiman KG
Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
[TBL] [Abstract][Full Text] [Related]
33. Genetic differences between paediatric and adult Burkitt lymphomas.
Havelange V; Pepermans X; Ameye G; Théate I; Callet-Bauchu E; Barin C; Penther D; Lippert E; Michaux L; Mugneret F; Dastugue N; Raphaël M; Vikkula M; Poirel HA
Br J Haematol; 2016 Apr; 173(1):137-44. PubMed ID: 26887776
[TBL] [Abstract][Full Text] [Related]
34. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
[TBL] [Abstract][Full Text] [Related]
35. Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells.
Mushtaq M; Darekar S; Klein G; Kashuba E
PLoS One; 2015; 10(8):e0136142. PubMed ID: 26312753
[TBL] [Abstract][Full Text] [Related]
36. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
Albert T; Urlbauer B; Kohlhuber F; Hammersen B; Eick D
Oncogene; 1994 Mar; 9(3):759-63. PubMed ID: 8108117
[TBL] [Abstract][Full Text] [Related]
37. The whole-genome landscape of Burkitt lymphoma subtypes.
Panea RI; Love CL; Shingleton JR; Reddy A; Bailey JA; Moormann AM; Otieno JA; Ong'echa JM; Oduor CI; Schroeder KMS; Masalu N; Chao NJ; Agajanian M; Major MB; Fedoriw Y; Richards KL; Rymkiewicz G; Miles RR; Alobeid B; Bhagat G; Flowers CR; Ondrejka SL; Hsi ED; Choi WWL; Au-Yeung RKH; Hartmann W; Lenz G; Meyerson H; Lin YY; Zhuang Y; Luftig MA; Waldrop A; Dave T; Thakkar D; Sahay H; Li G; Palus BC; Seshadri V; Kim SY; Gascoyne RD; Levy S; Mukhopadyay M; Dunson DB; Dave SS
Blood; 2019 Nov; 134(19):1598-1607. PubMed ID: 31558468
[TBL] [Abstract][Full Text] [Related]
38. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
[TBL] [Abstract][Full Text] [Related]
39. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
Greenough A; Dave SS
Curr Opin Hematol; 2014 Jul; 21(4):326-32. PubMed ID: 24867287
[TBL] [Abstract][Full Text] [Related]
40. Molecular and Cytogenetic Studies in a Child with Burkitt Lymphoma and Ataxia-Telangiectasia Syndrome Harboring MYC Overexpression and Partial Trisomy 8.
De Souza MT; Vera-Lozada G; Othman M; Marques-Salles TJ; Pinto LW; da Rocha MM; Rouxinol S; Liehr T; Ribeiro RC; Hassan R; Silva MLM
Ann Lab Med; 2018 Jan; 38(1):63-66. PubMed ID: 29071822
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
